Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Sundström

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Lakartidningen|February 27, 2010
[Clinical research must not appear as a necessary evil]Karin Sundström
Journal of the National Cancer Institute|June 30, 2026
Welcome reduction of US cervical cancer rates despite state differencesKarin Sundström
Plos One|August 22, 2020
Using machine learning for predicting cervical cancer from Swedish electronic health records by mining hierarchical representationsRebecka Weegar, Karin Sundström
The Journal of Infectious Diseases|September 17, 2020
How Many Human Papillomavirus Types Do We Need to Screen For?Karin Sundström, Joakim Dillner
Plos Medicine|January 29, 2020
Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?Karin Sundström, K Miriam Elfström
Preventive Medicine|December 28, 2020
Cervical screening in high-income countries: the need for quality assurance, adjunct biomarkers and rational adaptation to HPV vaccinationKarin Sundström, Eva Herweijer, Jiangrong Wang
Cancer|February 11, 2020
More evidence suggesting that 1-dose human papillomavirus vaccination may be effectiveJulia M L Brotherton, Karin Sundström
Journal of Medical Screening|April 30, 2026
Repeat invitations and participation in cervical screening: A population-based cohort studyNicholas Baltzer, Karin Sundström, Joakim Dillner
Plos One|February 19, 2021
Validation of the cobas 6800 human papillomavirus test in primary cervical screeningKarin Sundström, Helena Lamin, Joakim Dillner
BMJ Open|October 5, 2018
Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort studyTeresa Kreusch, Jiangrong Wang, Pär Sparén, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Lakartidningen|February 27, 2010
[Clinical research must not appear as a necessary evil]Karin Sundström
Journal of the National Cancer Institute|June 30, 2026
Welcome reduction of US cervical cancer rates despite state differencesKarin Sundström
Plos One|August 22, 2020
Using machine learning for predicting cervical cancer from Swedish electronic health records by mining hierarchical representationsRebecka Weegar, Karin Sundström
The Journal of Infectious Diseases|September 17, 2020
How Many Human Papillomavirus Types Do We Need to Screen For?Karin Sundström, Joakim Dillner
Plos Medicine|January 29, 2020
Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?Karin Sundström, K Miriam Elfström
Preventive Medicine|December 28, 2020
Cervical screening in high-income countries: the need for quality assurance, adjunct biomarkers and rational adaptation to HPV vaccinationKarin Sundström, Eva Herweijer, Jiangrong Wang
Cancer|February 11, 2020
More evidence suggesting that 1-dose human papillomavirus vaccination may be effectiveJulia M L Brotherton, Karin Sundström
Journal of Medical Screening|April 30, 2026
Repeat invitations and participation in cervical screening: A population-based cohort studyNicholas Baltzer, Karin Sundström, Joakim Dillner
Plos One|February 19, 2021
Validation of the cobas 6800 human papillomavirus test in primary cervical screeningKarin Sundström, Helena Lamin, Joakim Dillner
BMJ Open|October 5, 2018
Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort studyTeresa Kreusch, Jiangrong Wang, Pär Sparén, et al.
Pageof 11